Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 93 results for "glenmark pharmaceuticals"

Glenmark gets USFDA nod for generic blood pressure medicine
Money Control

Glenmark gets USFDA's approval to sell generic blood pressure ...

Glenmark's tablets will be manufactured by company's manufacturing facility located in Goa Business Standard, 12 hours ago

16 images for glenmark pharmaceuticals

Money Control, 1 week ago
Sify, 2 weeks ago
Money Control, 1 day ago
Money Control, 1 month ago, 3 months ago
Forbes India, 3 months ago, 4 months ago, 4 months ago
Pharmacy Times, 4 months ago
Hindu Business Line, 4 months ago
Money Control

S&P revises Glenmark outlook to negative on weaker cash flow

S Global Ratings today revised Glenmark Pharmaceuticals' outlook to negative from stable due to likely slower revenue growth with profitability constrained by natural price erosion. "The negative outlook reflects the risk of delayed deleveraging for Glenmark, ...
 DNA1 day ago SP revises Glenmark outlook to negative on weaker cash flow  Money Control1 day ago
Money Control

Glenmark Pharma hits 52-week low post Q4 results

The stock hit 52-week low of Rs 716, down 5.5%, extending its Friday's 16% on BSE.
 Business Standard1 week ago Glenmark Pharma tumbles as Q4 result miss market expectations  Business Standard2 weeks ago BUZZ-India's Glenmark Pharma slumps on Q4 profit miss  Sify2 weeks ago Glenmark Pharma sinks 16% as Q4 earnings miss estimates, sequentially profit tanks  Money Control2 weeks ago
Money Control

Glenmark anti-myeloma drug gets clinical trial nod from USFDA

The US health regulator has cleared Glenmark Pharma's investigational new drug application to initiate phase one study of GBR 1342, a humanised monoclonal antibody for treatment of multiple myeloma, the company said today.
 DNA1 week ago Glenmark Pharmaceuticals to initiate clinical study of GBR 1342  Business Standard1 week ago USFDA clears Glenmark's investigational new drug application  Money Control2 months ago Glenmark Pharma up 1% on US FDA nod to drug's first phase  Money Control2 months ago
Money Control

Market Live: Nifty opens above 9400, Sensex higher; Glenmark Pharma tanks 15%

Infosys, SBI, Tata Motors, HUL, MM, Bank of Baroda and Kotak Mahindra Bank were early gainers while TCS, Bharti Airtel, ICICI Bank, HDFC Bank, Axis Bank, Bharti Infratel and Indiabulls Housing were loser
 Money Control2 weeks ago Stocks in the news: Kotak Bank, SBI, Axis Bank, Rel Infra, Asian Paints, Glenmark  Money Control2 weeks ago
Money Control

10 key highlights of Glenmark Q4 earnings

The bottomline growth was impacted by Rs 81 crore exceptional item, high expenses and decline in sales across Europe, Latin America, and other markets. The expenses shot up 13.6 percent to Rs 2,152 crore on sequential basis. Here are a few key highlights from ...
 Money Control2 weeks ago Glenmark posts Rs 184 crore net profit in Q4; earnings below analyst estimates  Money Control2 weeks ago
Money Control

Growth a concern for Glenmark; Titan has become jewellery stock: Udayan Mukherjee

Titan#39;s EBIT from the jewellery business is ten times the EBIT from watches plus eyewear business put together, said Udayan Mukherjee.
 Money Control1 week ago
Money Control

Glenmark shares plummet 16%; mcap dips by Rs 4,090 cr

Shares of Glenmark Pharma today crashed over 16 per cent, wiping out Rs 4,090.56 crore from its market valuation, after the company's March quarter earnings failed to enthuse investors as its profit on sequential basis fell sharply.
 DNA2 weeks ago

Top buzzing midcap stocks to trade on May 12

Here are a few top buzzing midcap stocks picked by CNBC-TV18#39;s analysts in trade today -- Glenmark, Asian Paints, Jain Irrigation, Balaji Amines, VIP Clothing, Nilkamal, Pennar Engineering, Reliance Infrastructure, TD Power, Man Infra, Magma Fincorp, Yes ...
 Money Control2 weeks ago

Glenmark Pharmaceuticals biggest loser on BSE's 'A' group

Jain Irrigation Systems, Zee Entertainment Enterprises, Yes Bank and Alembic Pharmaceuticals are among the other losers in the BSE's 'A' group today, 12 May 2017.
 Business Standard2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less